Paydirt
TP
Insider

Third Rock Ventures GP IV, L.P.

10% owner

Third Rock Ventures GP IV, L.P. (10% owner) filed 2 Form 4 reports as a reporting entity in the past 24 months (0 purchases, 2 sales), most often in Tango Therapeutics, Inc. (TNGX). The largest single filing was $7.7M of TNGX (1,100,000 sh × $7.01, as filed), executed Aug 19 2025.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$9.8M
shares × price, as filed
Last traded
Aug 22 2025
Filed Aug 26 2025

Median ADV $98.9M across their filed names

Open performance
Volume by month
$9.8M$4.9M$0Oct 2024Apr 2025Oct 2025Apr 2026Aug 2025 · sells $9.8M
Buys $0 Sells $9.8M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 2 filings

Sector per market data · by filing · past 24 months

Most traded names
TNGX Tango Therapeutics, Inc. TNGX · 0 buys · 2 sells 2 filings
Recent filings
TNGXSALE Tango Therapeutics, Inc. View filing → $2.1M
302,194 sh × $7.00
Exec Aug 22 2025
Filed Aug 26 2025 · 5:30 PM ET
TNGXSALE Tango Therapeutics, Inc. View filing → $7.7M
1,100,000 sh × $7.01
Exec Aug 19 2025
Filed Aug 21 2025 · 5:30 PM ET